Scopus BioPharma Inc. Annual Share-based Payment Arrangement, Expense in USD from 2019 to 2022

Taxonomy & unit
us-gaap: USD
Description
Amount of expense for award under share-based payment arrangement. Excludes amount capitalized.
Summary
Scopus BioPharma Inc. quarterly/annual Share-based Payment Arrangement, Expense history and growth rate from 2019 to 2022.
  • Scopus BioPharma Inc. Share-based Payment Arrangement, Expense for the quarter ending June 30, 2023 was $78.1K, a 17.8% decline year-over-year.
  • Scopus BioPharma Inc. Share-based Payment Arrangement, Expense for the twelve months ending June 30, 2023 was $318K, a 35% decline year-over-year.
  • Scopus BioPharma Inc. annual Share-based Payment Arrangement, Expense for 2022 was $352K, a 47.5% decline from 2021.
  • Scopus BioPharma Inc. annual Share-based Payment Arrangement, Expense for 2021 was $670K, a 148% increase from 2020.
  • Scopus BioPharma Inc. annual Share-based Payment Arrangement, Expense for 2020 was $270K, a 117% increase from 2019.
Share-based Payment Arrangement, Expense, Trailing 12 Months (USD)
Share-based Payment Arrangement, Expense, Annual (USD)
Share-based Payment Arrangement, Expense, YoY Annual Growth (%)
Period Value YoY Chg Change % Start Date End Date Report Filed
2022 $352K -$318K -47.5% Jan 1, 2022 Dec 31, 2022 10-K 2023-04-14
2021 $670K +$399K +148% Jan 1, 2021 Dec 31, 2021 10-K 2023-04-14
2020 $270K +$146K +117% Jan 1, 2020 Dec 31, 2020 10-K 2022-04-15
2019 $124K Jan 1, 2019 Dec 31, 2019 10-K 2021-03-29
* An asterisk sign (*) next to the value indicates that the value is likely invalid.